Answers are grounded in this paper and cite their sources.
Experimental study demonstrates effective targeting of intraocular tumors, suggesting enhanced treatment safety.
TSPDT with chlorin e6 enables selective targeting of intraocular pathological tissues while preserving scleral and retinal integrity. Defining the therapeutic window and using real-time thermal monitoring enhances treatment safety. These findings lay a foundation for clinical protocols for uveal melanoma and other intraocular tumors.
No takes yet. Share an insight, caveat, or question.
Boiko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: